Diabetes

WASHINGTON (AP) — The Food and Drug Administration is lifting severe safety restrictions on the former blockbuster diabetes pill Avandia, citing recent data suggesting that the much-debated medication does not increase the risk of heart attack. The repeal means patients will no longer have to enroll in a special registry to be eligible to receive […]